Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BR964

Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores
Unstained: $185.00 Add to Cart
H&E (BR964s*): $185.00 Add to Cart

Microarray Panel:Breast invasive ductal carcinoma tissue microarray, containing 27 cases of breast invasive ductal carcinoma, 1 each of breast intraductal carcinoma, invasive lobular carcinoma, mucinous adenocarcinoma and cystosarcoma phyllodes, 2 breast tubular carcinoma, 3 each of breast medullary carcinoma and fibroadenoma, 5 breast hyperplasia, plus 4 normal breast tissue, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)
Cores:96
Cases:48
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112 
A Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
B Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
C Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
D Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
E Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
F Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
G Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
H Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Marked point
Legend: Bre - Breast

- Benign tumor, - Hyperplasia, - Malignant tumor, - Malignant tumor (stage 0), - Malignant tumor (stage I), - Malignant tumor (stage IB), - Malignant tumor (stage III), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 51 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A2 2 F 54 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
A3 3 F 44 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
A4 4 F 36 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
A5 5 F 63 Breast Invasive ductal carcinoma 1 IIIb T4N0M0 Malignant
A6 6 F 51 Breast Invasive ductal carcinoma 1 IIb T2N1M0 Malignant
A7 7 F 41 Breast Invasive ductal carcinoma (breast tissue) – IIb T3N0M0 Malignant
A8 8 F 42 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A9 9 F 46 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
A10 10 F 40 Breast Invasive ductal carcinoma 1 IIIb T4N0M0 Malignant
A11 11 F 60 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A12 12 F 51 Breast Invasive ductal carcinoma with necrosis 1 IIa T2N0M0 Malignant
B1 13 F 51 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
B2 14 F 54 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
B3 15 F 44 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B4 16 F 36 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B5 17 F 63 Breast Invasive ductal carcinoma 1 IIIb T4N0M0 Malignant
B6 18 F 51 Breast Invasive ductal carcinoma (sparse) – IIb T2N1M0 Malignant
B7 19 F 41 Breast Invasive ductal carcinoma 1 IIb T3N0M0 Malignant
B8 20 F 42 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
B9 21 F 46 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
B10 22 F 40 Breast Invasive ductal carcinoma 1 IIIb T4N0M0 Malignant
B11 23 F 60 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
B12 24 F 51 Breast Invasive ductal carcinoma with necrosis 1 IIa T2N0M0 Malignant
C1 25 F 66 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
C2 26 F 61 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C3 27 F 40 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C4 28 F 52 Breast Invasive ductal carcinoma 2 III T4N1M0 Malignant
C5 29 F 31 Breast Invasive ductal carcinoma 2 III T4N2M0 Malignant
C6 30 F 51 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C7 31 F 36 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
C8 32 F 37 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C9 33 F 47 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
C10 34 F 81 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
C11 35 F 53 Breast Invasive ductal carcinoma 2 IIIa T3N1M0 Malignant
C12 36 F 44 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
D1 37 F 66 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
D2 38 F 61 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
D3 39 F 40 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D4 40 F 52 Breast Invasive ductal carcinoma 2 III T4N1M0 Malignant
D5 41 F 31 Breast Invasive ductal carcinoma 2 III T4N2M0 Malignant
D6 42 F 51 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D7 43 F 36 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
D8 44 F 37 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D9 45 F 47 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
D10 46 F 81 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
D11 47 F 53 Breast Invasive ductal carcinoma 2 IIIa T3N1M0 Malignant
D12 48 F 44 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
E1 49 F 31 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
E2 50 F 60 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E3 51 F 62 Breast Invasive ductal carcinoma 3 IIIb T4N0M0 Malignant
E4 52 F 67 Breast Intraductal carcinoma – 0 TisN0M0 Malignant
E5 53 F 49 Breast Invasive lobular carcinoma – IIIa T3N2M0 Malignant
E6 54 F 66 Breast Mucinous adenocarcinoma 2 IIb T3N0M0 Malignant
E7 55 F 38 Breast Tubular carcinoma – IIa T2N0M0 Malignant
E8 56 F 50 Breast Tubular carcinoma – IIb T3N0M0 Malignant
E9 57 F 60 Breast Medullary carcinoma – IIIb T4bN1M0 Malignant
E10 58 F 48 Breast Medullary carcinoma – IIb T3N0M0 Malignant
E11 59 F 52 Breast Medullary carcinoma – IIa T2N0M0 Malignant
E12 60 F 35 Breast Low grade cystosarcoma phyllodes – IB T2N0M0 G1 Malignant
F1 61 F 31 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
F2 62 F 60 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
F3 63 F 62 Breast Invasive ductal carcinoma 3 IIIb T4N0M0 Malignant
F4 64 F 67 Breast Intraductal carcinoma – 0 TisN0M0 Malignant
F5 65 F 49 Breast Invasive lobular carcinoma – IIIa T3N2M0 Malignant
F6 66 F 66 Breast Mucinous adenocarcinoma 2 IIb T3N0M0 Malignant
F7 67 F 38 Breast Tubular carcinoma – IIa T2N0M0 Malignant
F8 68 F 50 Breast Tubular carcinoma – IIb T3N0M0 Malignant
F9 69 F 60 Breast Medullary carcinoma – IIIb T4bN1M0 Malignant
F10 70 F 48 Breast Medullary carcinoma – IIb T3N0M0 Malignant
F11 71 F 52 Breast Medullary carcinoma – IIa T2N0M0 Malignant
F12 72 F 35 Breast Low grade cystosarcoma phyllodes – IB T2N0M0 G1 Malignant
G1 73 F 23 Breast Fibroadenoma – – – Benign
G2 74 F 23 Breast Fibroadenoma – – – Benign
G3 75 F 30 Breast Fibroadenoma – – – Benign
G4 76 F 40 Breast Hyperplasia – – – Hyperplasia
G5 77 F 42 Breast Hyperplasia – – – Hyperplasia
G6 78 F 28 Breast Hyperplasia – – – Hyperplasia
G7 79 F 23 Breast Hyperplasia – – – Hyperplasia
G8 80 F 28 Breast Hyperplasia – – – Hyperplasia
G9 81 F 42 Breast Normal breast tissue with ductal ectasia – – – Normal
G10 82 F 21 Breast Normal breast tissue – – – Normal
G11 83 F 27 Breast Normal breast tissue – – – Normal
G12 84 F 19 Breast Normal breast tissue – – – Normal
H1 85 F 23 Breast Fibroadenoma – – – Benign
H2 86 F 23 Breast Fibroadenoma – – – Benign
H3 87 F 30 Breast Fibroadenoma – – – Benign
H4 88 F 40 Breast Hyperplasia – – – Hyperplasia
H5 89 F 42 Breast Hyperplasia with local epithelial proliferation – – – Hyperplasia
H6 90 F 28 Breast Hyperplasia – – – Hyperplasia
H7 91 F 23 Breast Hyperplasia – – – Hyperplasia
H8 92 F 28 Breast Hyperplasia – – – Hyperplasia
H9 93 F 42 Breast Normal breast tissue (fibrous tissue and blood vessel) – – – Normal
H10 94 F 21 Breast Normal breast tissue – – – Normal
H11 95 F 27 Breast Normal breast tissue – – – Normal
H12 96 F 19 Breast Normal breast tissue (fibrofatty tissue and blood vessel) – – – Normal
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal